Citations 0
Editor's Correspondence
June 23, 2008

Concomitance of Cardiovascular Comorbidities in the Hypertensive Population: Not Only in the United States

Author Affiliations

Copyright 2008 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2008

Arch Intern Med. 2008;168(12):1350-1351. doi:10.1001/archinte.168.12.1350-b

We read with interest the study by Wong et al1 describing the prevalence, treatment, and control of hypertension among US adults with and without cardiovascular (CV) comorbidities. In this study that included a total of 4646 patients, the overall prevalence of hypertension ranged from 23.1% in those without CV comorbidities to 51.8% to 81.8% in those with CV comorbidities. Interestingly, although hypertension treatment rates for diabetes mellitus, stroke, heart failure, and coronary artery disease were higher (83.4%-89.3%) than the rates for those without these conditions (66.5%) (P < .01), control rates for treatment remained poor (23.2%-49.3%) (P < .001 to P = .048).

First Page Preview View Large
First page PDF preview
First page PDF preview